Edison Tak‐bun Liu
#157,173
Most Influential Person Now
Edison Tak‐bun Liu's AcademicInfluence.com Rankings
Edison Tak‐bun Liubiology Degrees
Biology
#12176
World Rank
#15634
Historical Rank
Computational Biology
#263
World Rank
#264
Historical Rank
Genetics
#1325
World Rank
#1427
Historical Rank
Neuroscience
#2025
World Rank
#2081
Historical Rank

Download Badge
Biology
Edison Tak‐bun Liu's Degrees
- PhD Genetics University of California, San Diego
- Bachelors Biochemistry University of California, San Diego
Why Is Edison Tak‐bun Liu Influential?
(Suggest an Edit or Addition)Edison Tak‐bun Liu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- The Transcriptional Landscape of the Mammalian Genome (2005) (3394)
- Breast cancer classification and prognosis based on gene expression profiles from a population-based study (2003) (2060)
- International network of cancer genome projects (2010) (1839)
- An Oestrogen Receptor α-bound Human Chromatin Interactome (2009) (1476)
- Genome-wide analysis of mammalian promoter architecture and evolution (2006) (1317)
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. (2005) (1301)
- A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome (2006) (1172)
- Extensive Promoter-Centered Chromatin Interactions Provide a Topological Basis for Transcription Regulation (2012) (1142)
- Pharmacologic disruption of Polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. (2007) (887)
- CTCF-Mediated Human 3D Genome Architecture Reveals Chromatin Topology for Transcription (2015) (769)
- Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts (2005) (762)
- High-fidelity mRNA amplification for gene profiling (2000) (715)
- Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. (2006) (690)
- RNA Viral Community in Human Feces: Prevalence of Plant Pathogenic Viruses (2005) (624)
- Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells (1994) (615)
- Evolution of the mammalian transcription factor binding repertoire via transposable elements. (2008) (480)
- Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection (2003) (479)
- Whole-Genome Cartography of Estrogen Receptor α Binding Sites (2007) (435)
- A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci (2010) (358)
- Next-generation DNA sequencing of paired-end tags (PET) for transcriptome and genome analyses. (2009) (356)
- Transcriptome Analysis of Zebrafish Embryogenesis Using Microarrays (2005) (328)
- Discovery of estrogen receptor α target genes and response elements in breast tumor cells (2004) (306)
- Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. (2002) (296)
- Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients (2006) (294)
- Telomerase directly regulates NF-κB-dependent transcription (2012) (294)
- Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression (2006) (289)
- Identification of c-myc responsive genes using rat cDNA microarray. (2000) (278)
- Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. (2002) (265)
- Gene identification signature (GIS) analysis for transcriptome characterization and genome annotation (2005) (262)
- Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. (2005) (251)
- DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. (2008) (227)
- Gene expression profiles derived from fine needle aspiration correlate with response to systemic chemotherapy in breast cancer (2002) (227)
- Transcriptome Profiling of Human and Murine ESCs Identifies Divergent Paths Required to Maintain the Stem Cell State (2005) (217)
- The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast. (1992) (215)
- Regulation of Transcription through Acetylation of H3K122 on the Lateral Surface of the Histone Octamer (2013) (211)
- Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin. (2010) (208)
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy (2017) (203)
- Initiating oncogenic event determines gene-expression patterns of human breast cancer models (2002) (196)
- Identification of cell cycle-regulated genes in fission yeast. (2005) (193)
- Mouse Models for Cancer Immunotherapy Research. (2018) (186)
- The Carolina Breast Cancer Study: integrating population-based epidemiology and molecular biology (1995) (180)
- Integrative model of genomic factors for determining binding site selection by estrogen receptor-α (2010) (179)
- Cellular reprogramming by the conjoint action of ERα, FOXA1, and GATA3 to a ligand-inducible growth state (2011) (179)
- Optimal gene expression analysis by microarrays. (2002) (178)
- Differential activation of the Ras/extracellular-signal-regulated protein kinase pathway is responsible for the biological consequences induced by the Axl receptor tyrosine kinase (1996) (171)
- Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling (2005) (170)
- Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. (2006) (170)
- BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents (2001) (165)
- BRCA1-associated growth arrest is RB-dependent. (1999) (165)
- Multiple mechanisms induce transcriptional silencing of a subset of genes, including oestrogen receptor α, in response to deacetylase inhibition by valproic acid and trichostatin A (2005) (160)
- p53-regulated Transcriptional Program Associated with Genotoxic Stress-induced Apoptosis* (2004) (151)
- Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. (2008) (150)
- Receptor tyrosine kinases expressed in metastatic colon cancer (1995) (149)
- Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. (2001) (146)
- RCP is a human breast cancer-promoting gene with Ras-activating function. (2009) (133)
- Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. (2005) (132)
- THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma (2005) (130)
- Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells. (2012) (130)
- Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes (2003) (130)
- Identification of a large Myc-binding protein that contains RCC1-like repeats. (1998) (129)
- Genome-wide dynamics of chromatin binding of estrogen receptors alpha and beta: mutual restriction and competitive site selection. (2010) (125)
- Tracking the evolution of the SARS coronavirus using high-throughput, high-density resequencing arrays. (2004) (118)
- Genetic background is an important determinant of metastatic potential (2003) (115)
- Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach (2004) (115)
- Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. (2002) (115)
- Transcriptional regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose- and time-dependent effects. (2002) (114)
- GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma (2011) (114)
- Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. (2002) (112)
- p53 gene alterations in human prostate carcinoma. (1993) (112)
- De-Novo Identification of PPARγ/RXR Binding Sites and Direct Targets during Adipogenesis (2009) (112)
- Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer (2007) (111)
- The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations (2017) (110)
- Global Expression Profiling Identifies Signatures of Tumor Virulence in MMTV-PyMT-Transgenic Mice (2004) (110)
- Alterations of the P53 gene are associated with the progression of a human prostate carcinoma. (1992) (109)
- 5' Long serial analysis of gene expression (LongSAGE) and 3' LongSAGE for transcriptome characterization and genome annotation. (2004) (107)
- Systems Biology, Integrative Biology, Predictive Biology (2005) (106)
- Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles (2015) (106)
- Regulation of Estrogen Receptor-mediated Long Range Transcription via Evolutionarily Conserved Distal Response Elements* (2008) (100)
- Large-Scale Functional Organization of Long-Range Chromatin Interaction Networks (2012) (100)
- Systematic Deletion Analysis of Fission Yeast Protein Kinases (2005) (95)
- JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer (2012) (95)
- Silencing of Wnt Signaling and Activation of Multiple Metabolic Pathways in Response to Thyroid Hormone-Stimulated Cell Proliferation (2001) (93)
- Differential sensitivity of cancer cells to inhibitors of the epidermal growth factor receptor family (2002) (93)
- Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma (2003) (93)
- Identification of Src transformation fingerprint in human colon cancer (2002) (92)
- The feasibility of using fine needle aspiration from primary breast cancers for cDNA microarray analyses. (2002) (91)
- Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors (2005) (91)
- BRCA1 Is a Selective Co-activator of 14-3-3ς Gene Transcription in Mouse Embryonic Stem Cells* 210 (2001) (91)
- The tandem duplicator phenotype as a distinct genomic configuration in cancer (2016) (89)
- Her-2/neu and Topoisomerase iiα in Breast Cancer (2003) (87)
- Mechanism of tandem duplication formation in BRCA1 mutant cells (2017) (87)
- Transcriptome kinetics of arsenic-induced adaptive response in zebrafish liver. (2006) (86)
- A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection (2004) (83)
- Transcriptional consequences of genomic structural aberrations in breast cancer. (2011) (81)
- Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes. (2011) (81)
- Zebrafish Whole-Adult-Organism Chemogenomics for Large-Scale Predictive and Discovery Chemical Biology (2008) (78)
- Microarrays and clinical investigations. (2004) (76)
- Oncogenic human papillomavirus type 16 is associated with squamous cell cancer of the male urethra. (1992) (76)
- Gene expression correlating with response to paclitaxel in ovarian carcinoma xenografts. (2004) (76)
- Human chondrocyte expression of growth-arrest-specific gene 6 and the tyrosine kinase receptor axl: potential role in autocrine signaling in cartilage. (1997) (73)
- Novel protein kinases expressed in human breast cancer (1993) (72)
- Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy (2015) (69)
- Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma. (2010) (68)
- Mutational dynamics of the SARS coronavirus in cell culture and human populations isolated in 2003 (2004) (68)
- Structural mutations in cancer: mechanistic and functional insights. (2012) (67)
- Picky Comprehensively Detects High Resolution Structural Variants in Nanopore Long Reads (2018) (67)
- Polymerase chain reaction based assay to detect allelic loss in human DNA: loss of β-interleron gene in chronic myelogeneous leukemia (1990) (66)
- Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. (2008) (66)
- Expression of the matrix Gla protein in urogenital malignancies (1992) (62)
- Interrogating the transcriptome. (2004) (61)
- HOXA1-stimulated oncogenicity is mediated by selective upregulation of components of the p44/42 MAP kinase pathway in human mammary carcinoma cells (2007) (60)
- Expression of growth factor receptors, the focal adhesion kinase, and other tyrosine kinases in human soft tissue tumors (2006) (60)
- cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene. (2002) (58)
- Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators (2013) (58)
- Gold-nanoparticle-based assay for instantaneous detection of nuclear hormone receptor-response elements interactions. (2010) (58)
- Multiplatform genome-wide identification and modeling of functional human estrogen receptor binding sites (2006) (56)
- In the pursuit of complexity: systems medicine in cancer biology. (2006) (56)
- Self-assembled monolayer-assisted silicon nanowire biosensor for detection of protein-DNA interactions in nuclear extracts from breast cancer cell. (2011) (55)
- Apoptotic susceptibility of cancer cells selected for camptothecin resistance: gene expression profiling, functional analysis, and molecular interaction mapping. (2003) (55)
- Simultaneous amplification of HER-2 (ERBB2) and topoisomerase IIalpha (TOP2A) genes--molecular basis for combination chemotherapy in cancer. (2006) (54)
- A gene harvest revealing the archeology and complexity of human disease (2007) (54)
- Different gene expression profiles between microsatellite instability-high and microsatellite stable colorectal carcinomas (2004) (52)
- Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study (2006) (52)
- Detection of Severe Acute Respiratory Syndrome Coronavirus in Blood of Infected Patients (2004) (52)
- Oncogenes and Tumor Suppressor Genes in Human Malignancies (2012) (52)
- Genome-wide expression profiling; a panel of mouse tissues discloses novel biological functions of liver X receptors in adrenals. (2004) (52)
- BRCA1 Interacts with and Is Required for Paclitaxel-Induced Activation of Mitogen-Activated Protein Kinase Kinase Kinase 3 (2004) (51)
- Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility (2010) (51)
- Classification of cancers by expression profiling. (2003) (51)
- Fine mapping of the 11q22–23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma (2004) (50)
- Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. (1992) (49)
- Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma* (2005) (49)
- Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer (2011) (48)
- Linkage Disequilibrium Mapping of CHEK2: Common Variation and Breast Cancer Risk (2006) (47)
- Q&A: ChIP-seq technologies and the study of gene regulation (2010) (47)
- Core biopsies can be used to distinguish differences in expression profiling by cDNA microarrays. (2002) (46)
- Multi-tissue gene-expression analysis in a mouse model of thyroid hormone resistance (2004) (45)
- Topoisomerase IIα gene (TOP2A) amplification and deletion in cancer – more common than anticipated (2003) (45)
- ESR1 and EGF genetic variation in relation to breast cancer risk and survival (2008) (45)
- Detection of Chromosomal Breakpoints in Patients with Developmental Delay and Speech Disorders (2014) (45)
- Liver X receptors regulate adrenal steroidogenesis and hypothalamic-pituitary-adrenal feedback. (2007) (44)
- Expression genomics in breast cancer research: microarrays at the crossroads of biology and medicine (2007) (43)
- Activation of the Axl receptor tyrosine kinase induces mitogenesis and transformation in 32D cells. (1994) (42)
- SARS Transmission Pattern in Singapore Reassessed by Viral Sequence Variation Analysis (2005) (42)
- BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. (2001) (42)
- Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma (2010) (42)
- Characterization of Mice Deficient in the Src Family Nonreceptor Tyrosine Kinase Frk/rak (2002) (39)
- Risk of breast cancer according to the status of HER-2/neu oncogene amplification. (2000) (39)
- Frequent decreased expression of candidate tumor suppressor gene, DEC1, and its anchorage‐independent growth properties and impact on global gene expression in esophageal carcinoma (2008) (38)
- Breast cancer cell line proliferation blocked by the Src‐related Rak tyrosine kinase (2003) (38)
- Heterogeneous epigenetic regulation of TIMP3 in prostate cancer (2012) (38)
- Protein kinases in human breast cancer (1995) (37)
- Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays. (2001) (35)
- Molecular conservation of estrogen-response associated with cell cycle regulation, hormonal carcinogenesis and cancer in zebrafish and human cancer cell lines (2011) (33)
- Highly sensitive and reversible silicon nanowire biosensor to study nuclear hormone receptor protein and response element DNA interactions. (2010) (33)
- BRCA1-mediated repression of select X chromosome genes (2004) (31)
- A bioinformatics-based strategy identifies c-Myc and Cdc25A as candidates for the Apmt mammary tumor latency modifiers. (2002) (31)
- Monochromosome Transfer and Microarray Analysis Identify a Critical Tumor-Suppressive Region Mapping to Chromosome 13q14 and THSD1 in Esophageal Carcinoma (2008) (30)
- HER2 as a predictor of therapeutic response in breast cancer. (2000) (30)
- Identification of Myc-mediated Death Response Pathways by Microarray Analysis* (2002) (29)
- Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study (2006) (29)
- Systems consequences of amplicon formation in human breast cancer (2014) (29)
- Identifying gene expression changes in breast cancer that distinguish early and late relapse among uncured patients (2006) (28)
- HER-2/neu and topoisomerase IIalpha in breast cancer. (2003) (27)
- Global Profiling of DNA Replication Timing and Efficiency Reveals that Efficient Replication/Firing Occurs Late during S-Phase in S. pombe (2007) (25)
- Functional genomics of cancer. (2008) (25)
- Transcriptome profiling of estrogen-regulated genes in human primary osteoblasts reveals an osteoblast-specific regulation of the insulin-like growth factor binding protein 4 gene. (2008) (24)
- HER-2/neu and topoisomerase IIalpha--simultaneous drug targets in cancer. (2003) (24)
- FANCM regulates repair pathway choice at stalled replication forks. (2021) (23)
- Susceptibility to cell death induced by blockade of MAPK pathway in human colorectal cancer cells carrying Ras mutations is dependent on p53 status. (2004) (23)
- Of mice and CRISPR (2017) (22)
- Mechanism-derived gene expression signatures and predictive biomarkers in clinical oncology. (2005) (22)
- Effects of HER-2/neu on chemosensitivity of tumor cells. (2000) (21)
- PPARG Binding Landscapes in Macrophages Suggest a Genome-Wide Contribution of PU.1 to Divergent PPARG Binding in Human and Mouse (2012) (21)
- Long Span DNA Paired-End-Tag (DNA-PET) Sequencing Strategy for the Interrogation of Genomic Structural Mutations and Fusion-Point-Guided Reconstruction of Amplicons (2012) (21)
- The tyrosine kinase FRK/RAK participates in cytokine-induced islet cell cytotoxicity. (2004) (20)
- Xenopus tropicalis Genome Re-Scaffolding and Re-Annotation Reach the Resolution Required for In Vivo ChIA-PET Analysis (2015) (20)
- Effect of ATM, CHEK2 and ERBB2 TAGSNPs and haplotypes on endometrial cancer risk. (2007) (19)
- Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators (2017) (18)
- Defining the galaxy of gene expression in breast cancer (2002) (18)
- Company Says It Mapped Part of SARS Virus (2003) (17)
- Pyrosequencing enhancement for better detection limit and sequencing homopolymers. (2010) (15)
- Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer (2011) (15)
- Prediction of early distant relapses on tamoxifen in early-stage breast cancer (BC): A potential tool for adjuvant aromatase inhibitor (AI) tailoring (2005) (15)
- Strategy for the design of custom cDNA microarrays. (2003) (15)
- Primate-Specific Endogenous Cis-Antisense Transcription in the Human 5q31 Protocadherin Gene Cluster (2005) (15)
- Bridging tumor genomics to patient outcomes through an integrated patient-derived xenograft platform. (2015) (15)
- BEARR: Batch Extraction and Analysis of cis-Regulatory Regions (2004) (14)
- Of mice and CRISPR The post-CRISPR future of the mouse as a model system for the human condition (2017) (14)
- Molecular oncodiagnostics: where we are and where we need to go. (2003) (14)
- Gene profile and response to treatment. (2005) (13)
- Juvenile myelomonocytic leukemia (JMML) with the hematologic phenotype of severe β thalassemia (1998) (13)
- Pathway aberrations of murine melanoma cells observed in Paired-End diTag transcriptomes (2007) (13)
- Molecular profiles of invasive mucinous and ductal carcinomas of the breast: a molecular case study. (2003) (13)
- P57 (KIP2) polymorphisms and breast cancer risk (1999) (13)
- The Cinderella effect: searching for the best fit between mouse models and human diseases. (2013) (13)
- Expression genomics and drug development: towards predictive pharmacology. (2005) (13)
- High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts (2018) (13)
- BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. (1996) (13)
- FANCM regulates repair pathway choice at stalled replication forks (2020) (12)
- Differential polymerase chain reaction in the analysis of gene dosage. (1993) (12)
- Stromal effects in breast cancer. (2007) (12)
- The Archon Genomics X PRIZE for whole human genome sequencing (2010) (12)
- Integrative biology — a strategy for systems biomedicine (2009) (12)
- Integrative biology and systems biology (2005) (12)
- Judging the Archon Genomics X PRIZE for whole human genome sequencing (2011) (11)
- Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014 (2017) (11)
- Reduced subgenomic RNA expression is a molecular indicator of asymptomatic SARS-CoV-2 infection (2021) (10)
- Oncogenes, breast cancer, and chemoprevention (1993) (10)
- Corrigendum to: Integrative genomics of gene and metabolic regulation by estrogen receptors and, and their coregulators (Molecular Systems Biology, (2014), 9, 1, (676), 10.1038/msb.2013.28) (2017) (9)
- Higher order structure in the cancer transcriptome and systems medicine (2007) (9)
- Microarray Gene Expression Profiling of Angiogenesis Inhibitors Using the Rat Aortic Ring Assay (2002) (9)
- Functional chromatin features are associated with structural mutations in cancer (2014) (8)
- Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development (2009) (8)
- Genomic and molecular classification of breast cancer (2006) (8)
- Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia (2020) (8)
- A bioinformatics tool to select sequences for microarray studies of mouse models of oncogenesis (2002) (8)
- Cancer genomes. (2010) (7)
- Expression genomics and cancer biology. (2004) (7)
- CORRECTIONS (1994) (7)
- Patient-Derived Tumor Xenografts: Why Now? (2016) (7)
- Ha-ras rare alleles in breast cancer susceptibility (2004) (7)
- Validation of Transgenic Mammary Cancer Models: Goals of the NCI Mouse Models of Human Cancer Consortium and the Mammary Cancer CD-ROM (2002) (7)
- Artemin is estrogen regulated and mediates antiestrogen resistance in mammary carcinoma (2012) (7)
- Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes (2001) (6)
- Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assay. (2002) (6)
- Viruses and Oncogenes (1988) (6)
- Long Span Paired-EndTag Mapping Reveals Characteristic Patterns of Structural Variations in Epithelial Cancer Genomes (2011) (6)
- Cellular Regulatory Networks (2010) (5)
- Subgenomic RNAs as molecular indicators of asymptomatic SARS-CoV-2 infection (2021) (5)
- The Human Genome Organisation (HUGO) (2009) (5)
- Personalized medicine: does the molecular suit fit? (2013) (5)
- With a different voice: Integrating the psychosocial perspective into routine oncology care (1995) (5)
- The role of ras gene mutations in myeloproliferative disorders. (1990) (4)
- Gene Array Technologies in Biological Investigations (2005) (4)
- Cellular Proto-oncogenes (1988) (4)
- Alterations in the Rho pathway contribute to Epstein-Barr virus-induced lymphomagenesis in immunosuppressed environments. (2018) (4)
- Nanopore Sequencing Reveals High-Resolution Structural Variation in the Cancer Genome (2017) (4)
- Expression genomics and cancer drug development (2004) (4)
- Corrigendum: Genome-wide analysis of mammalian promoter architecture and evolution (2007) (4)
- Growth Factors and Receptors (1988) (4)
- Chromatin topology reorganization and transcription repression by PML-RARα in acute promyeloid leukemia (2020) (3)
- Lipid-laden lung mesenchymal cells foster breast cancer metastasis via metabolic reprogramming of tumor cells and natural killer cells. (2022) (3)
- Reply to Watkins et al.: Whole-genome sequencing-based identification of diverse tandem duplicator phenotypes in human cancers (2016) (3)
- New technologies for high-throughput analysis. (2005) (3)
- General keynote: expression profiling and the study of ovarian cancer. (2003) (3)
- The Genome Institute of Singapore (2005) (3)
- Human genome meeting 2016 (2016) (3)
- Oncogenes: An Introduction to the Concept of Cancer Genes (2012) (2)
- src and Related Protein Kinases (1988) (2)
- Oncogenes and Human Cancers (1988) (2)
- Genomics takes hold in Asia. Interview by David Cyranoski. (2008) (2)
- Core biopsy versus surgical tumor specimens for microarray analysis of gene expression profiles (2001) (2)
- Personalized Cancer Medicine 2011: Toward Individualized Cancer Treatments. XV International Fritz Bender Symposium Held on February 21 to 23, 2011 at Matrix, Biopolis, Singapore. (2011) (2)
- Animals, quality and the pursuit of relevance (2022) (2)
- The JAX patient-derived xenograft program: A unique resource to advance genome-guided cancer medicine and therapeutic agent testing. (2014) (2)
- Functional Complementation and Gene Expression Profile Analysis Identified THSD1 at 13q14 as a Novel Candidate Tumor Suppressor Gene for Esophageal Squamous Cell Carcinoma (2008) (2)
- Archon Genomics X PRIZE Validation Protocol (2011) (2)
- A Genomically and Clinically Annotated Patient-Derived Xenograft Resource for Preclinical Research in Non–Small Cell Lung Cancer (2022) (2)
- Towards a causative function of histone modifications in regulation of chromatin dynamics and transcription (2013) (2)
- Grappling with Cancer (2013) (2)
- Tumor Origins Through Genomic Profiles. (2019) (2)
- The Specialized Program of Research Excellence in breast cancer at the University of North Carolina at Chapel Hill (1995) (2)
- Potential Diagnostic Uses of Oncogenes (1988) (2)
- Molecular profiling of metastatic tumor progression of a murine squamous cell carcinoma by differential display and cDNA microarray reveals dysregulated expression of genes related to the nuclear factor-κb signal pathway (2001) (2)
- myc and Other Nuclear Oncogenes (1988) (2)
- BRCA1 Is a Selective Co-activator of 14-3-3s Gene Transcription in Mouse (2001) (2)
- Genomic technologies and the interrogation of the transcriptome (2005) (2)
- Personalizing medicine (2010) (2)
- Expression profiling and breast cancer biology. (2004) (1)
- Assays: Tools of the New Biology (1988) (1)
- Erratum to: JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer (2017) (1)
- Quantitative Biology and Clinical Trials: A Perspective (2010) (1)
- A bioinformatics tool to mine sequences for microarray studies of mouse models of oncogenesis (1999) (1)
- Employees’ Views and Ethical, Legal, and Social Implications Assessment of Voluntary Workplace Genomic Testing (2021) (1)
- Functional chromatin features are associated with structural mutations in cancer (2014) (1)
- Genome-wide analysis of mammalian promoter architecture and evolution (vol 38, pg 626, 2006) (2007) (1)
- Genomic Technologies for Systems Biology (2010) (1)
- Use of the Rat Gene Index to examine gene expression patterns from Src-transformed rat fibroblasts that exhibit broad differences in metastatic potential (1999) (1)
- JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer (2012) (1)
- Clinical Genomicist in the Future of Medical Practice (2012) (1)
- Abstract 5676: Patient-derived tumor xenografts in humanized NSG-SGM3 mice: An improved immuno-oncology platform (2018) (1)
- CHAPTER 24 – Biobanking in the Post-Genome Era (2009) (0)
- Oncogene Paradigm: Contribution to a Fundamental Understanding of Malignancy (1988) (0)
- The impact of the bioethics advisory committee on the research community in Singapore (2010) (0)
- Corrections (1965) (0)
- Molecular characterization of an extensive lung cancer patient-derived xenograft (PDX) resource. (2014) (0)
- Abstract B137: Oncogenic chromosomal blocks in cancer genomes. (2013) (0)
- Representational oligonucleotide microarray analysis (ROMA) in pharmacogenomics (2004) (0)
- Position Paper on the Testing of DNA and Tissue in Human Research (2002) (0)
- Somatic genetics and signaling/genomics/proteomics (2003) (0)
- Technology developments and applications (2009) (0)
- Systems Biology in Cancer Medicine: Combinatorics and the Long Tail (2014) (0)
- 585 Genomics of Metastatic Progression in Cutaneous Melanoma (2012) (0)
- Advances in Technology and Their Implications for Global Pharmaceutical Development (2006) (0)
- HER-2/neu neu and topoisomerase IIα α in breast cancer (2003) (0)
- Differential global effects of selective estrogen receptor modulators on estrogen receptor binding and transcriptional regulation (2007) (0)
- SELF-ASSEMBLED MONOLAYER-ASSISTED SILICON NANOWIRE BIOSENSOR FOR STUDYING PROTEIN-DNA INTERACTIONS (2010) (0)
- Abstract P6-06-02: Molecular characterization of a patient-derived xenograft (PDX) resource for triple negative breast cancer (2015) (0)
- Abstract LB-32: Patient-derived xenograft (PDX) paraclinical platform to guide precision medicine in urothelial cancer (2014) (0)
- Foundations for Systems Biomedicine (2009) (0)
- Transgenic Mice: Direct In Vivo Assay for Oncogenes (1988) (0)
- ras Family of Oncogenes (1988) (0)
- A patient-derived xenograft (PDX) platform to optimize omics-driven precision medicine in bladder cancer. (2014) (0)
- Discussion: Somatic Genetics and Signaling/Genomics/Proteomics (2003) (0)
- Prospective study for comprehensive genomic profiling (GP) in cancer of unknown primary (CUP): Feasibility, molecular landscape, and clinical utility in current era. (2020) (0)
- The Role of the Novel Nuclear Tyrosine Kinase, RAK, in Breast Cancer Biology (1997) (0)
- Abstract P1-03-05: Patient-derived xenografts in humanized mice classify metastatic potential of primary triple negative breast cancer (2020) (0)
- Identification of c-myc target genes using a rat cDNA microarray (1999) (0)
- 606 Defining the Molecular States of Cancer and Stem Cells Through Integrative Transcriptional and Genomic Analysis (2012) (0)
- Abstract A47: DNA-PKcs is amplified in high-grade serous ovarian cancer (HGSC), correlates with poor outcome and drives resistance to platinum therapy via the AKT signaling pathway (2015) (0)
- Abstract 3180:In vitrotool for discovering oncogenes and tumor suppressor genes in a system's manner. (2013) (0)
- 283 P53 Mutations in Arylaminc- and Smoking-induced Human Bladder Cancer (1995) (0)
- 27th HUGO-IABCR Congress 2010: Oral Presentation Abstracts, 5–7 October 2010, Singapore (2010) (0)
- SYSTEMS PHARMACOLOGY IN CANCER THERAPEUTICS: ITERATIVE INFORMATICS-EXPERIMENTAL INTERFACE (2008) (0)
- Abstract IA29: Mice host selection for patient-derived xenograft (PDX) model development and other critical factors for success (2016) (0)
- Genome-wide analysis of mammalian promoter architecture and evolution based upon human and mouse CAGE data, Supplementary Data (2006) (0)
- Risk of Breast Cancer According to the Status of HER-2 / neu Oncogene Amplification 1 (2000) (0)
- Abstract 2411: Evolution during propagation and treatment of patient-derived triple negative breast cancer xenografts (2016) (0)
- Development and characterization of patient-derived xenografts to guide precision medicine in bladder cancer. (2015) (0)
- Evolution of an intratumoral ecology susceptible to successive treatment in breast cancer xenografts (2018) (0)
- Abstract 3414: Genomic signatures of melanoma maintenance (2014) (0)
- Abstract 2909: High-precision quantification of clonal evolution during comparative treatments of triple negative breast cancer (2017) (0)
- Mapping of the estrogen receptor: GATA-3 interactome in MCF-7 human mammary carcinoma cells (2007) (0)
- A Chloroform-Assisted Protein Isolation Method Followed by Capillary NanoLC-MS Identify Estrogen-Regulated Proteins from MCF7 Cells (2010) (0)
- Abstract IA13: The Patient-Derived Xenograft Program at The Jackson Laboratory (2016) (0)
- Human T Cell Lymphotropic/Leukemia Viruses (1988) (0)
- HGV2009 meeting: bigger and better studies provide more answers and more questions (2010) (0)
- Utilization of a 358-gene panel to molecularly profile solid tumors for association with target-based therapeutic agents. (2014) (0)
- Systems Pharmacology in Cancer (2010) (0)
- Functional genomics of complex cancer genomes (2022) (0)
- Q U E S T I O N & A N S W E R Open Access (2010) (0)
- Epigenetic factors that control estrogen receptor alpha (ERα) binding site utilization and specificity in the MCF-7 human breast cancer cell line (2007) (0)
- Understanding mechanism of estrogen receptor mediated gene regulation in MCF7 and Ishikawa cell lines (2007) (0)
- Abstract GS1-05: Tandem duplicator phenotypes define 50% of triple negative breast cancers (2018) (0)
- SILICON NANOWIRE BIOSENSOR FOR STUDYING NUCLEAR HORMONE RECEPTOR AND RESPONSE ELEMENT INTERACTIONS (2010) (0)
- Xenograft Platform Could Lead to Mouse-Based Clinical Trials (2018) (0)
- Commentary Defining the galaxy of gene expression in breast cancer (2002) (0)
- Questions about comparative genomics of SARS coronavirus isolates (2003) (0)
- Transcriptional Regulation and Cancer Genomics (2008) (0)
- Mammary gland involution studies with cDNA microarrays (1999) (0)
- Dose-and Time-dependent Effects Camptothecin-induced DNA Damage : Microarray Analysis of Transcriptional Regulation of Mitotic Genes by Updated (2002) (0)
- Genome-Wide Dynamics of Chromatin Binding of Estrogen Receptors (cid:1) and (cid:2) : Mutual Restriction and Competitive Site Selection (2009) (0)
- Abstract 3998: The role of serum amyloid A1 (SAA1) in nasopharyngeal carcinoma (NPC) (2012) (0)
- Singapore tissue network in supporting biomedical research in Singapore (2007) (0)
- Abstract 4947: Analysis of structural mutations in cancer genomes (2012) (0)
- Towards a causative function of histone modifications in regulation of chromatin dynamics and transcription (2013) (0)
- PPARg/RXR transcriptional circuitry governing adipocyte biology (2007) (0)
- The emergence of ‘The HUGO Journal’ (2009) (0)
- Oncogenic Human Papi Homa virus Type 16 Is Associated with Squamous Cell Cancer of the Male Urethra 1 (2006) (0)
- Patient-derived xenograft platform to guide precision medicine in bladder cancer. (2015) (0)
- Abstract 114: Study of the high-grade ovarian cancer precursors in the oviduct (2012) (0)
- Abstract 5107: Unravelling the complexity of individual cancer genomes (2012) (0)
- Differential gene expression in cells with targeted deletion of BRCA1 tumor suppressor (2001) (0)
- Potential Therapeutic Applications of Oncogenes (1988) (0)
- Gene expression in prostate cancer: microarray analysis of tumor specimens from African American and Caucasian patients (2001) (0)
- transcriptome and genome analyses Next-generation DNA sequencing of paired-end tags ( PET ) for (2009) (0)
- Patient-derived bladder cancer xenografts as a platform for drug development in bladder cancer. (2015) (0)
- Silencing of Wnt signaling and activation of multiple metabolic pathways in response to cell proliferation stimulated by thyroid hormone (2001) (0)
- Abstract 2001: Genomic signatures of melanoma progression and maintenance. (2013) (0)
- Gene expression profiles of low- and high-grade papillary serous ovarian carcinomas using cDNA microarray analysis (2001) (0)
- - Axl: Axl protein-tyrosine kinase (vertebrates) [UFO (human, mouse), Ark (mouse)] (1995) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Edison Tak‐bun Liu?
Edison Tak‐bun Liu is affiliated with the following schools: